More Recce Pharmaceuticals Ltd. news
Recce Pharmaceuticals Ltd.ASX: RCE

License and Commercialisation Agreement in AUS/NZ for R327G

Oct 21, 2026 at 6:45 PM EDT · Issued by Recce Pharmaceuticals Ltd.

Filed with ASX · Oct 21, 2026 at 6:45 PM EDT

On 6ix: 6ix.com/news/license-and-commercialisation-agreement-in-ausnz-for-r327g

View Attachment

6ix is reading this filing.

Recce Pharmaceuticals Ltd. on 6ix

Earlier from Recce Pharmaceuticals

  • Independent Review of Indonesian Phase 3 R327G Trial DataOct 19
  • Amendments to Debt Facility with Avenue Capital GroupOct 16
  • Appendix 4E and FY26 Annual ReportAug 31
  • HREC Approves Comparator Study for Pivotal Phase 3 DFIAug 18
  • Vietnamese Patent Granted for RECCE Anti-InfectivesJul 13
All Recce Pharmaceuticals news releases↗

Follow Recce Pharmaceuticals into a list and get an email when it puts out news.

Follow Recce Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer